קמפטו
pfizer pfe pharmaceuticals israel ltd - irinotecan hydrochloride - תמיסה לאינפוזיה - irinotecan hydrochloride 20 mg/ml - irinotecan - irinotecan - campto is indicated for the treatment of patients with metastatic colorectal cancer: in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. as a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen. for the treatment of patients with small cell lung cancer. for the treatment of patients with gastric cancer.
אירינוטקאן זריקות 20 מ"ג/מ"ל
novapharma ltd - irinotecan (trihydrate) hydrochloride 20 mg/ml - concentrate for solution for infusion - irinotecan - irinotecan is indicated for the treatment of patients with metastatic colorectal cancer: - in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. - as a single agent in patients who have failed an astablished 5-fluorouracil containing treatment regimen. for the treatment of patients with small cell lung cancer. for the treatment of patients with gastric cancer.
אירינוטקאן טבע ®
salomon,levin & elstein ltd - irinotecan hydrochloride trihydrate 20 mg / 1 ml - concentrate for solution for infusion - irinotecan - irinotecan is indicated for the treatment of patients with metastatic colorectal cancer: - in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. - as a single agent in patients who have failed an astablished 5-fluorouracil containing treatment regimen. for the treatment of patients with small cell lung cancer. for the treatment of patients with gastric cancer.
אירינוטקן " אבווה, 20 מ"ג / מ"ל
pharmalogic ltd - irinotecan hydrochloride trihydrate 20 mg / 1 ml - concentrate for solution for infusion - irinotecan - irinotecan is indicated for the treatment of patients with metastatic colorectal cancer: - in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. - as a single agent in patients who have failed an astablished 5-fluorouracil containing treatment regimen. for the treatment of patients with small cell lung cancer. for the treatment of patients with gastric cancer.
אירינוטקן טבע
abic marketing ltd, israel - irinotecan hydrochloride trihydrate - תרכיז להכנת תמיסה לאינפוזיה - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan
אירינוטקן הידרוכלוריד סיקרוס 20 מגמל
a.l. medi-market ltd. - irinotecan hydrochloride trihydrate - תרכיז להכנת תמיסה לאינפוזיה - irinotecan hydrochloride trihydrate 20 mg / 1 ml - irinotecan